These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26305981)

  • 21. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological response in cryo-immunotherapy of malignant tumors--the mechanism of the rise and fall of NK activity and cytotoxic T lymphocytes after inoculation of Cryo-destructed Meth A cells].
    Nakazawa M
    Osaka Daigaku Shigaku Zasshi; 1985 Jun; 30(1):60-86. PubMed ID: 3878396
    [No Abstract]   [Full Text] [Related]  

  • 24. Innate immune recognition and suppression of tumors.
    Hayakawa Y; Smyth MJ
    Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
    Rosenberg S
    J Natl Cancer Inst; 1985 Oct; 75(4):595-603. PubMed ID: 3876465
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer immunotherapy using NKG2D and DNAM-1 systems.
    Morisaki T; Onishi H; Katano M
    Anticancer Res; 2012 Jun; 32(6):2241-7. PubMed ID: 22641658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer T cell-based cancer immunotherapy.
    van der Vliet HJ; Balk SP; Exley MA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5921-3. PubMed ID: 17062661
    [No Abstract]   [Full Text] [Related]  

  • 28. NK cells--from basic research to cancer therapy.
    Cerwenka A; Falk CS; Watzl C
    Eur J Immunol; 2007 May; 37(5):1161-4. PubMed ID: 17447232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming of natural killer cells and their use in immunotherapies of solid tumors.
    Matosevic S
    Immunotherapy; 2020 Jun; 12(9):605-608. PubMed ID: 32418468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genetically modified cells as vectors of local secretion of cytokines. Perspectives in antitumoral immunotherapy].
    Roth C; Quintin-Colonna F; Devauchelle P; Kourilsky P
    Bull Cancer; 1995 Mar; 82(3):227-8. PubMed ID: 7655157
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of activated natural killer cells for tumor immunotherapy in mouse and human.
    Basse PH; Whiteside TL; Herberman RB
    Methods Mol Biol; 2000; 121():81-94. PubMed ID: 10818719
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.
    Smyth MJ; Wallace ME; Nutt SL; Yagita H; Godfrey DI; Hayakawa Y
    J Exp Med; 2005 Jun; 201(12):1973-85. PubMed ID: 15967825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
    Shurin MR; Gregory M; Morris JC; Malyguine AM
    Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Unleashing NK cell signaling to improve cancer immunotherapy].
    Bernard PL; Laletin V; Pastor S; Nunès JA; Guittard G
    Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():50-55. PubMed ID: 33052095
    [No Abstract]   [Full Text] [Related]  

  • 36. Natural killer cell-based immunotherapeutic strategies.
    Klingemann HG
    Cytotherapy; 2005; 7(1):16-22. PubMed ID: 16040380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 38. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The path to reactivation of antitumor immunity and checkpoint immunotherapy.
    Kim HJ; Cantor H
    Cancer Immunol Res; 2014 Oct; 2(10):926-36. PubMed ID: 25281320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New aspects of natural-killer-cell surveillance and therapy of cancer.
    Smyth MJ; Hayakawa Y; Takeda K; Yagita H
    Nat Rev Cancer; 2002 Nov; 2(11):850-61. PubMed ID: 12415255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.